SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today announced its acquisition of infusion set developer, Capillary ...

PAW PAW, MI –– It’s long after practice is over on a late November afternoon and AJ Rickli and Grace Mitchell are rigorously firing away 3-pointers and diligently working on the details of each their ...

Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) has been given an average rating of “Moderate Buy” by the seventeen analysts that are presently covering the firm, MarketBeat.com reports.

“Ease of use is what drives adoption,” CEO John Sheridan explains to Bloomberg Intelligence about what can drive further insulin pump penetration. In this episode of Vanguards of Health Care, Sheridan ...